Pharmacologic therapy of non-alcoholic steatohepatitis
- PMID: 19818312
- DOI: 10.1016/j.cld.2009.07.001
Pharmacologic therapy of non-alcoholic steatohepatitis
Abstract
Specific therapy for non-alcoholic steatohepatitis (NASH) is needed because of the potential severity of this liver disease. NASH is a recognized cause of cryptogenic cirrhosis and, increasingly, of hepatocellular carcinoma. Therefore, there is an unmet medical need for the therapy of NASH. This article discusses this therapy, with particular emphasis on pharmacologic therapy.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
